期刊文献+

高原地区不同民族抗结核药物所致肝损伤临床特点分析 被引量:1

Clinical Characteristics of Liver Injury Caused by Anti Tuberculosis Drugs in Different Nationalities in Plateau Area
下载PDF
导出
摘要 目的分析青海地区抗结核药物所致肝损伤的发生率和易感因素。方法选取本院收治的1 197例初治肺结核患者作为研究对象,统计患者肝功能损伤发生率,分析不同民族、不同年龄、不同性别及化疗药物的影响。结果发生肝功能损伤52例,总发生率为4.43%;不同民族肝功能损伤发生率分别为:汉族1.17%,藏族2.25%,回族0.75%,其他民族0.17%。汉族与藏族比较差异有统计学意义(P<0.05),回族与藏族比较差异有统计学意义(P<0.05);不同年龄肝功能损伤发生率分别为:≥60岁3.76%,<60岁0.58%。组间比较差异有统计学意义(P<0.05);不同性别肝功能损伤发生率分别为:男性2.17%,女性2.17%。两组患者男女比例比较差异无统计学意义(P>0.05);化疗药物导致的肝功能损伤发生率分别为:异烟肼0.17%、利福平1.59%、吡嗪酰胺2.18%。结论高原地区抗结核药物所致的肝损伤发生率为4.43%,藏族发生率最高、年龄≥60岁发生率较高,化疗药物中吡嗪酰胺发生率最高。 Objective To investigate the incidence and risk factors of liver injury caused by anti tuberculosis drugs in Qinghai area. Methods A total of 1 197 cases of primary pulmonary tuberculosis treated in our hospital were selected as the subjects.The incidence of liver function injury was analyzed,and the effects of different nationalities,different ages,different sex and chemotherapeutic drugs were analyzed. Results There were 52 cases of liver function injury,the total incidence rate was 4.43%,and the incidence of liver function injury in different nationalities was 1.17%,2.25%,0.75% and 0.17% of the other ethnic groups.There was a significant difference between the Han and the Tibetans(P<0.05),as well as between the Hui and the Tibetans(P<0.05). The incidence of liver function injury at different ages were:3.76% in those ≥ 60 years,0.58% in those<60 years,and the difference between groups was statistically significant(P<0.05);the incidence of liver dysfunction in different genders was 2.17% and 2.17% respectively,without significant difference(P>0.05). The incidence of liver function injury caused by chemotherapeutic drugs was isoniazid 0.17%,rifampicin 1.59%,and 2.18% of pyrazinamide. Conclusion The incidence of liver injury caused by anti-tuberculosis drugs was 4.43% in high altitude area,among which Tibetans had the highest incidence,age ≥ 60 years old had the highest incidence,and the incidence of pyrazinamide among chemotherapy drugs was the highest.
作者 丁月荷 雷琼 李秀萍 DING Yuehe;LEI Qiong;LI Xiuping(Qinghai Fourth People's Hospital,Xining,Qinghai 810000,China)
出处 《大医生》 2018年第7期164-165,共2页 Doctor
关键词 抗结核药物 肝损伤 不同民族 化疗 anti tuberculosis drugs liver injury different ethnicity chemotherapy
  • 相关文献

参考文献4

二级参考文献41

  • 1殷素素,何钟宓.抗结核药物致肝损害116例临床分析[J].华西医学,2008,23(5):1065-1067. 被引量:11
  • 2徐中南,吴锡铭,王佩,张喜全,夏春光,王训强,王鸯,湛筱乐,曲颖,徐铭益,陆伦根.18α甘草酸对D-氨基半乳糖引起的大鼠急性肝损伤治疗作用[J].临床肝胆病杂志,2012,28(1):63-65. 被引量:7
  • 3郭虹,李环,李淑芬,王淑玲.抗结核药物治疗对肝功能的影响[J].北华大学学报(自然科学版),2005,6(5):425-427. 被引量:14
  • 4Turktas H,Unsal M,Tulek N,et al.Hepatotoxicity of anti-tuberculosis therapy (rifampicin,isoniazidand and pyrazinamide) or Viral hepatitis[J].Tuber Lung Dis,1994,75:58.
  • 5Agal S,Bai JR,Pramanik S,et al.Monitoring and management of antituberculosis drug induced hepatotoxicity[J].Gastroenterology and Hepatology,2005,20 (11):1745 -1752.
  • 6Fernandez VA.Sopefia B,Fernandez VJ,et al.The influence of risk factors on the severity of antituberculosis drug-induced hepatotoxicity[J].Tuberc Lung Dis,2004,8(12):1499-1505.
  • 7邵世峰 李丽.抗结核药物性肝损害的临床分析.Tianjin Med J,2007,:716-717.
  • 8Shakya R,Rao BS,Shrestha B.Incidence of hepatotoxicity due to antitubercular medicines and assessment of risk factors[J].Ann Pharmacother,2004,38 (6):1074-1079.
  • 9Wong WM,Wu PC,Yuen MF,et al.Antituberculosis drug-related liver dysfunction in chronic hepatitis Binfection[J].Hepatology,2000,31 (1):201-206.
  • 10Col AC,Anand VSM,Lt CK,et al.Risk Factors of Hepatotoxicity During Anti-tuberculosis Treatment[J].MJAFI,2006,62:45-49.

共引文献55

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部